We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPACU
4251
DELISTED
Bullpen Parlay Acquisition Company Unit
BPACU
-900,000
Closed -$9.13M
MGI
4252
DELISTED
MoneyGram International, Inc. New
MGI
-473,995
Closed -$3.74M
TCRR
4253
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-68,493
Closed -$320K
QTEK
4254
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
-67,029
Closed -$665K
SGTX
4255
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-290
Closed -$10K
SDIG
4256
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
-8,126
Closed -$1.04M
VMGAU
4257
DELISTED
VMG Consumer Acquisition Corp. Unit
VMGAU
-425,000
Closed -$4.31M
VNTR
4258
DELISTED
Venator Materials PLC
VNTR
-13,903
Closed -$35K
SVNAU
4259
DELISTED
7 Acquisition Corp Unit
SVNAU
-850,000
Closed -$8.62M
ADALU
4260
DELISTED
Anthemis Digital Acquisitions I Corp Unit
ADALU
-4
Closed
BBBY
4261
DELISTED
Bed Bath & Beyond Inc
BBBY
-31,480
Closed -$459K
TRAQ.U
4262
DELISTED
Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant
TRAQ.U
-2
Closed
EUCR
4263
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
-963
Closed -$9K
IBA
4264
DELISTED
Industrias Bachoco SAB De C.V.
IBA
-2,152
Closed -$92K
PLXP
4265
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-11,084
Closed -$89K
GLS
4266
DELISTED
Gelesis Holdings, Inc.
GLS
-1,751,059
Closed -$17.4M
AUY
4267
DELISTED
Yamana Gold, Inc.
AUY
-2,050,373
Closed -$8.65M
ATCO
4268
DELISTED
Atlas Corp.
ATCO
-4,497
Closed -$64K
RAAS
4269
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
-11,444
Closed -$100K
MYOV
4270
DELISTED
Myovant Sciences Ltd.
MYOV
-54,193
Closed -$844K
VVNT
4271
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
-13,000
Closed -$127K
HORIU
4272
DELISTED
Emerging Markets Horizon Corp. Unit
HORIU
-250,000
Closed -$2.5M
CNCE
4273
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-45,383
Closed -$143K
ALBO
4274
DELISTED
Albireo Pharma Inc
ALBO
-129,126
Closed -$3.01M
RNERU
4275
DELISTED
Mount Rainier Acquisition Corp. Unit
RNERU
-818,281
Closed -$8.32M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.